Combination of clomipramine and nortriptyline in the treatment of obsessive-compulsive disorder: A double-blind, placebo-controlled trial

Journal of Clinical Pharmacy and Therapeutics

Volumn 23, Issue 2, 1998, Pages 155-159

  Noorbala, A A ^a   Hosseini, S H ^a   Mohammadi, M R ^a   Akhondzadeh, S ^a,b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b NONE   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CLOMIPRAMINE; NORTRIPTYLINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HUMAN; HYPOTHESIS; MALE; NORADRENERGIC SYSTEM; OBSESSION; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM;

ADRENERGIC UPTAKE INHIBITORS; ADULT; CLOMIPRAMINE; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; NORTRIPTYLINE; OBSESSIVE-COMPULSIVE DISORDER; PLACEBOS; SEROTONIN UPTAKE INHIBITORS;

EID: 0031707363     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2710.1998.00156.x     Document Type: Article

References (21)

1. Kaplan HI, Sadock BJ. (1995) Comprehensive Textbook of Psychiatry/VI. Williams & Wilkins, Baltimore.
2. Park LT, Jefferson JW, Greist JH. (1997) Obsessive-compulsive disorder: treatment options. CNS Drugs, 3, 187-202.
3. Macro P, Stefano P, Cesario B, et al. (1995) Efficacy of drug treatment in obsessive-compulsive disorder. A metaanalytic review. British Journal of Psychiatry, 166, 424-443.
4. Zohar J, Insel TR, Zohar-Kadouch RC, et al. (1988) Serotonergic responsivity in obsessive-compulsive disorder: effects of chronic clomipramine treatment. Archive of General Psychiatry, 45, 167-172.
5. Benkelfat C, Murphy DL, Zohar J, et al. (1989) Clomipramine in obsessive-compulsive disorder: further evidence for a serotonergic mechanism of action. Archive of General Psychiatry, 46, 23-28.
6. Jenike MA, Baer L, Summergrad P, et al. (1990) Sertraline in obsessive-compulsive disorder: a double-blind comparison with placebo. American Journal of Psychiatry, 147, 923-928.
7. Greist JH, Chouinard G, Duboff E, et al. (1995) Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder. Archive of General Psychiatry, 52, 289-295.
8. Hollander E, Fay M, Cohen RN, et al. (1988) Serotonergic and noradrenergic sensitivity in obsessive-compulsive disorder: behavioral findings. American Journal of Psychiatry, 145, 1015-1017.
9. Jenike MA, Hyman S, Baer L, et al. (1990) A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory. American Journal of Psychiatry, 147, 1209-1215.
10. Rauch SL, O'Sullivan RL, Jenike MA. (1996) Open treatment of obsessive-compulsive disorder with venlafaxine: a series of ten cases [letter]. Journal of Clinical Psychopharmacology, 16, 81-84.
11. Richelson E, Pfenning M. (1984) Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake. European Journal of Pharmacology, 104, 277-286.
12. Bolden-Watson C, Richelson E. (1993) Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes. Life Science, 52, 1023-1029.
13. American Psychiatric Association. (1994) Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM-IV). American Psychiatric Press, Washington, DC.
14. Goodman WK, Price LH, Rasmussen SA, et al. (1989) The Yale-Brown Obsessive-Compulsive Scale. Archive of General Psychiatry, 46, 1006-1011.
15. Hamilton M. (1960) A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 56.
16. Insel TR, Murphy DL, Cohen RM, et al. (1983) Obsessive-compulsive disorder: a double-blind trial of clomipramine and clorgyline. Archive of General Psychiatry, 40, 605-612.
17. Zohar J, Insel T. (1987) Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology. Biological Psychiatry, 22, 667-687.
18. Charney DS, Goodman WK, Price LH, et al. (1988) Serotonin function in obsessive-compulsive disorder. Archive of General Psychiatry, 45, 177-185.
19. Jenike MA, Baer L, Greist JH. (1990) Clomipramine versus fluoxetine in obsessive-compulsive disorder: a retrospective comparison of side-effects and efficacy. Journal of Clinical Psychopharmacology, 10, 122-124.
20. Pigott TA, Pato MT, Bernstein SE, et al. (1990) Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder: behavioral and biological results. Archive of General Psychiatry, 47, 926-932.
21. Rosenthal R. (1984) Meta-analytic Procedures for Social Research. Sage, Beverly Hills.